NICE sets out how to diagnose and treat Lyme disease
New NICE guidance will help GPs, specialists and other health professionals spot a potential diagnosis of Lyme disease.
Most common ear infections should not be treated with antibiotics, says NICE
NICE is urging GPs to manage most common ear infections with pain relief rather than antibiotics.
NICE says not to give up on people trying to be independent after hospital discharge or in their own homes
NICE is urging health and social care staff to support people to safely continue with everyday activities such as climbing stairs, dressing themselves or cooking after a period of illness or if they have been struggling at home.
Nivolumab now available for lung cancer after company offers NICE new CDF deal
Lung cancer patients in England can now be prescribed nivolumab, also known as Opdivo, after NICE says it should be available through the Cancer Drugs Fund (CDF).
Latest news headlines
-
NICE to begin review of its guidance on the diagnosis and treatment of CFS/ME
NICE is to begin a review of its 2010 guideline on the diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) following a recent public consultation with patient and professional groups.
20 September 2017
-
More than a million people should be offered lifestyle tips as a way to avoid type 2 diabetes
People at the highest risk of type 2 diabetes should be given intensive exercise and weight loss help by the NHS, NICE has recommended.
15 September 2017
-
Sepsis - what NICE says
NICE urges all professionals across the NHS to think 'could this be sepsis?' Find out what else NICE says to tackle this life-threatening condition.
13 September 2017
-
Look out for people at risk of having ADHD diagnosis missed, says NICE
NICE is urging doctors to think about a potential ADHD diagnosis in people who are at higher risk of having the condition, but who are usually overlooked.
06 September 2017
-
Suspect endometriosis in women with chronic pelvic pain, says NICE.
Delayed diagnosis is a significant problem for women with endometriosis, NICE has said, as new guidance aims to raise awareness amongst healthcare professionals.
06 September 2017
-
NICE says benefits of breast cancer drug fulvestrant too uncertain to make it cost effective
NICE has published draft guidance saying the evidence on using fulvestrant to treat a type of breast cancer does not prove it prolongs survival more than existing, less expensive treatments.
01 September 2017